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Abstract
Background: Rising national cesarean section rates (CSRs) and unexplained inter-hospital differences in CSRs, led national and
international bodies to select CSR as a quality indicator. Using hospital discharge abstracts, we aimed to document in Belgium
(1) inter-hospital differences in CSRs among low risk deliveries, (2) a national upward CSR trend, (3) lack of better neonatal
outcomes in hospitals with high CSRs, and (4) possible under-use of CS.
Methods: We defined a population of low risk deliveries (singleton, vertex, full-term, live born, <4500 g, >2499 g). Using
multivariable logistic regression techniques, we provided degrees of evidence regarding the observed departure ([relative risk-
1]*100) of each hospital (N = 107) from the national CSR and its trend. To determine a benchmark, we defined three CSR
groups (high, average and low) and compared them regarding 1 minute Apgar scores and other neonatal endpoints. An
anonymous feedback is provided to the hospitals, the College of Physicians (with voluntary disclosure of the outlying hospitals
for quality improvement purposes) and to the policy makers.
Results: Compared with available information, the completeness and accuracy of the data, regarding the variables selected to
determine our study population, showed adequate. Important inter-hospital differences were found. Departures ranged from -
65% up to +75%, and 9 "high CSR" and 13 "low CSR" outlying hospitals were identified. We observed a national increasing trend
of 1.019 (95%CI [1.015; 1.022]) per semester, adjusted for age groups. In the "high CSR" group 1 minute Apgar scores < 4 were
over-represented in the subgroup of vaginal deliveries, suggesting CSs not carried out for medical reasons. Under-use of CS was
also observed. Given their questionable completeness, except Apgar scores, our neonatal results, showing a significant
association of CS with adverse neonatal endpoints, are to be cautiously interpreted. Taking the available evidence into account,
the "Average CSR" group seemed to be the best benchmark candidate.
Conclusion: Rather than firm statements about quality of care, our results are to be considered a useful screening. The inter-
hospital differences in CSR, the national CS upward trend, the indications of over-use and under-use, the geographically different
obstetric patterns and the admission day-related concentration of deliveries, whether or not by CS, may trigger initiatives aiming
at improving quality of care.
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Over the past few decades, there has been a tremendous
rise in the number of deliveries performed through cesar-
ean section in most industrialized countries. While both
longitudinal as well as cross-sectional variations in cesar-
ean section rates would be expected to reflect primarily
differences in obstetric complications, it is actually
observed that wide differences occur between countries,
regions or even hospitals within the same region with sim-
ilar socio-economic profiles and patient characteristics
[1,2]. The latter seems to suggest that CS is probably often
performed for non-medical reasons leading to an overall
overuse of this surgical obstetric intervention. Indeed, it
has been acknowledged that elective primary and repeat
CS contributed heavily to the cesarean rise [3,4]. In the US
for instance, the overall CSR increased by some 14% from
1998 to 2001 as a result of a 13% increase in medically
indicated primary CS, yet a 53% increase in the rate of
elective primary CS [3]. Similarly, vaginal birth after cesar-
ean delivery (VBAC) rates decreased by 27% between
1996 and 2000, because of the rare but potentially cata-
strophic risks and medical litigation [4,5].
Meikl et al[3] describe elective caesarean as:" Elective
cesarean deliveries can include medically and obstetrically
indicated procedures that generally occur before labor.
Elective cesarean deliveries can also include procedures
for which there is no clear medical or obstetric indica-
tion." In the framework of a quality indicator, which aims
at to monitor and reduce the caesarean rate [1], both
aspects of their description are to be considered.
When comparing the CSRs between hospitals it is then
important to exclude from the comparison medically and
obstetrically indicated cesarean sections[4] and only to
include procedures for which there is no clear medical or
obstetric indication. We will call the latter type of cesarean
sections: "elective cesareans" in the remainder of this
manuscript. We also consider a repeat cesarean as medi-
cally and obstetrically indicated and therefore to be
excluded from the comparison.
It is difficult to strike a balance between elective CS, which
we understand as a procedure that occurred before labor,
and vaginal delivery in the absence of randomized con-
trolled trials [2].
Yet, it appears to be well established that in case of
uncomplicated pregnancy, cesarean section exposes the
parturient to inadvertent risks without offering a defined
benefit [6]. The increase in the incidence of placenta
accreta (from 1/30,000 pregnancies in the 1950s to 1/533
nowadays) and its dramatic consequences mainly have
been ascribed to the increased CSR [7]. As a matter of fact,
several studies revealed that the overall increase in cesar-
ean rates has not led to a general decrease in perinatal
mortality or birth asphyxia [8,9] and some countries with
rather low CSRs experience low perinatal mortality rates,
suggesting that good perinatal outcome does not necessar-
ily equate high CSRs [10]. Nonetheless some authors
argue that elective CS is as safe as or even safer than vagi-
nal delivery [11].
Financial reasons and relative easiness may play a part in
the mode of delivery decision-making, and when analyz-
ing data on the subject, it can be difficult to distinguish
between patient's or physician's choice [2,6,12]. Informed
consent, maternal preferences, maternal autonomy, and
the physician factor may play a role as well. Finally,
decreasing parity (most women have less than two preg-
nancies) and medico-legal considerations can also con-
tribute to the decision process [6,11,13].
Though it proves difficult to pinpoint the adequacy of
obstetric care at the patient level. There is a defined need
to monitor cesarean rates at the national, regional, and
hospital levels to detect both over- and under-use[10] of
CS. The use of CSR as a quality indicator in some coun-
tries, the contribution of informed consent and societal
considerations to the decision-making process as well as
clinical and epidemiological considerations, and the
knowledge that CRS can be safely reduced by targeted
interventions, led us to use CSR as a quality indicator of
health care [1,14,15]. As CSR is a process indicator rather
than an outcome itself, we also tried to demonstrate that
CSR affects neonatal outcomes [16].
In the present population-based study, we used hospital
discharge abstracts to select a predefined population of
low risk deliveries and we subsequently aimed to explore
the presence of both statistically and clinically significant
inter-hospital differences in hospital-specific CSRs. We
further hypothesized that hospitals with a high CSR
would not experience better neonatal outcomes. Possible
under-use was also to be evaluated.
Methods
Data sources
Since October 1990 all Belgian hospitals are subjected to
compulsory registration with the health authorities of
each admission through a standard form containing a
defined set of clinical data including ICD-coded diagnoses
and procedures. These discharge abstracts are termed Min-
imal Clinical Data (MCD) and contain patient data
(among which year of birth, gender, residence, and anon-
ymous hospital and patient identifiers), stay data (among
which year and month of admission and discharge, length
of stay, transfer to another hospital with specification of
the type of hospital) and an unlimited number of diag-
noses and procedures. This information is transmitted toPage 2 of 16
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are further characterized according to teaching status
(teaching or non-teaching), ownership (private or public)
and the presence or absence of intensive maternal or neo-
natal care or otherwise. Hence, the MCD database covers
all stays in Belgian hospitals, including those of non-resi-
dents. Because of the absence of a unique patient identi-
fier, it is not possible, in case of a neonatal transfer, to get
matching maternal and infant data in the "intake" hospi-
tal. Conversely all these data are available in the "dis-
charge" facility's data.
In order to assess possible incompleteness and/or inaccu-
racy of the data – which are well-known drawbacks of
administrative data [17] – we compared the MCD data
with various partially overlapping registries, in particular
data extracted from (1) the National Institute of Statistics
(NIS), which are confined to residents, (2) the Center for
the Study of Perinatal Epidemiology (SPE), a population-
based perinatal data registry, confined to Flanders, the
Northern half of the country, and (3) published data from
the Office de la Naissance et de l'Enfance (ONE), provid-
ing perinatal data regarding the Southern part of the coun-
try [18].
In the SPE registry all perinatal deaths and live births
occurring in the participating Flemish obstetrical units
(residents and non-residents) are recorded, as well as a
proportion of the home deliveries (about 1% of all deliv-
eries). The data are collected on a routine and continuous
basis and are submitted to an organized system of quality
insurance [19]. The NIS data may be considered almost
complete and of good quality as these data originate from
the register of births, deaths and marriages, frequently
used for administrative purposes. The ONE data regarding
Apgar score and birth weight may be considered complete
[20].
Definition of the study population
A valid inter-hospital comparison of CSRs requires an
adjustment for case mix. Alternatively, a population with
a presumably equal risk of obstetric intervention may be
defined for further analysis. Accordingly, we aimed to
define a subgroup of parturients which is considered at
low-risk of having a medically indicated CS [21], by
excluding any patient that could have been considered at
increased risk for a CS according to the US Agency for
Healthcare Research and Quality (AHRQ) [1].
We excluded all deliveries involving abnormal presenta-
tion (including breech) or breech procedure, preterm ges-
tation (< 37 weeks), fetal death, and multiple gestations
according to the criteria of the US AHRQ. On request of
the Belgian College of Physicians we further excluded all
cases of full-term small-for-gestational age (defined as
newborns born after 36 completed weeks of gestation
with a birth weight of less than 2500 g) or macrosomia
(defined as by birth weight of at least 4500 g).
All above-mentioned maternal characteristics were identi-
fied by Diagnosis Related Group (DRG) or by diagnosis
and procedure codes of the International Classification of
Diseases 9th Revision Clinical Modification (ICD-9-CM).
(Precise ICD-9-CM diagnosis and procedure codes can be
found on the AHRQ's website [3].
The sampling frame consisted of the 455,933 deliveries,
involving live born singletons in vertex presentation that
were registered from 2001 to 2004. Thereof 86,310
(18.96%) were classified as cesarean deliveries. By apply-
ing the aforementioned criteria the final data set, the study
population, comprised 381,989 deliveries of which 49,578
(12.98%) by cesarean section. Out of the 73, 944 deliver-
ies, not meeting these criteria, 36,732 (49,68%) were
cesarean deliveries, the comparison population.
Analysis
Our aim was to identify, on the one hand, hospitals, with
higher quality of obstetric care for benchmark and exem-
plary function purposes, and, on the other hand, hospitals
with lower quality of care in order to help them improve
their processes.
To assess hospital-specific rates of CS relative to the over-
all CS rate two analyses were carried out: a cross-sectional
one focusing on the CSRs for the entire time span of the
study (we call it the period) and a longitudinal one (we
call it the trend) focusing on the per-semester evolution of
the CSRs. In the latter analysis the unit of time used is the
semester, the first semester comprising the first six months
of the calendar year.
It has been suggested that in analyses, founded on admin-
istrative databases, confounding cannot be ruled out as an
explanation of rather small, yet statistically significant
effect sizes, such as a relative risk (RR) of 0.75 [22]. There-
fore we defined a zone of non-interpretation, where the
CS rate or trend of a hospital, compared with the national
ones, should not be described as being "higher" or
"lower". To determine the boundaries of this zone we
firstly computed per hospital the relative risk (RR) of a
hospital of having a higher/lower CS rate or trend than the
national the national ones. We then calculated a depar-
ture D (expressed in %): with the formula D = (RR-1) ×
100. Subsequently we defined the lower boundary as cor-
responding to a departure of minus 25 – which is equiva-
lent to the afore-mentioned RR of 0.75 – and the upper
boundary as a departure of plus 35, the lower boundary's
approximate, statistical counterpart.Page 3 of 16
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of departures from the CS trend and by assuming that data
quality has remained constant over time, a similar zone of
non-interpretation was defined to allow for a comparison
in the evolution over time in the hospital-specific CS rates
by which we arbitrarily allowed for a -5 to +5 departure
from the national trend. In the other cases, characterized
by important departures, the results of the analysis were
interpreted according to the degree of statistical evidence.
We labeled this evidence 1) "strong" if the probability of
finding a departure, as important or bigger than that of
the hospital under consideration, is smaller than or equal
to 0.05/number of hospitals to be compared (the so-
called Bonferroni correction for multiple compari-
sons[23]); 2) "moderate" if that probability is smaller
than or equal to 0.05 but greater than 0.05/number of
hospitals to be compared; 3) "weak" otherwise.
Study goals
The results of the analysis had to serve three purposes: to
deliver (1) a feedback to the hospitals so they can improve
care processes, (2) a feedback to the Belgian College of
Physicians that will enable them to support hospitals
identified with higher or lower quality, and (3) a feedback
to health authorities as a useful tool for policy making.
The feedback to the hospitals consists mainly of a graphi-
cal display of the "departure" of all of the hospitals from
the national rate/trend, of an anonymous and tabular rep-
resentation of these departures as well as of an indication
of the level of statistical evidence. An aid in the interpreta-
tion, combining the information of both the period and
trend analyses, is provided alongside. Its decision tree is
given in the Annex of the Supplementary materials (see
Additional file 1).
In the feedback to the Belgian College of Physicians we
present an average and two outlying categories of hospi-
tals. A first, outlying category, the 'high CSR' group, con-
sists of those hospitals with a departure of > +35 and
statistically significant (Bonferroni-corrected). A second,
outlying category, the 'low CSR' group, consists of those
hospitals with a departure of < -25 and statistically signif-
icant (Bonferroni-corrected). The other hospitals are
grouped into the 'average CSR' group. The decision tree is
identical to that for the hospitals, except that hospitals rec-
ommended for an external audit are now divided in "high
CSR" and "low CSR" groups and that the other hospitals
are regrouped in an "average CSR" group.
Neonatal endpoints
As the optimal CSR is unknown, we compared the three
CSR groups with respect to a number of selected neonatal
endpoints like respiratory distress syndrome (RDS),
meconium aspiration syndrome (MAS) and transient
tachypnea of newborn (TTN), the main causes of neonatal
morbidity [24,25]. We selected 1-minute and 5-minute
Apgar scores [26]; RDS, MAS, TTN (ICD-9-CM codes 769,
770.1 and 770.6); need of respiration sustaining treat-
ments; and admission into a specialized neonatal service
as neonatal endpoints. Notice that in our view 1-minute
Apgar scores, essentially indicating fetal distress, are rather
used as a process, reflecting the degree of accordance of
the obstetrical care to fetal status, than as an outcome
indicator. The 5-minute Apgar scores would allow the
identification of cases vaginally delivered that might have
benefited of a CS.
In order to reduce inter-observer variability and according
to the literature we regrouped the Apgar scores into three
categories: "Apgar 0–3," "Apgar 4–6," and "Apgar > 6"
[27,28]. The completeness of the data regarding Apgar
scores may be more secure than that of the other neonatal
endpoints since they are recorded by means of explicitly
to-be-filled-out items whereas the others are open-ques-
tion-like observations a hospital may or may not register.
To determine the possible influence of major congenital
anomalies on the perinatal endpoints (see Additional file
2), we planned to twice carry out our analyses: once
including and once excluding the cases of congenital
anomalies [29].
Statistical methods
For our analyses we used so-called fixed effects models,
because we focused on the whole of the Belgian hospitals
and aimed at the identification of outlying hospitals, i.e.
characterized by an important and statistically significant,
Bonferroni-corrected [23] departure from the national
CSR or CSR evolution over time. Given we cover the short
time span of eight semesters, we only fitted models with a
linear time trend, which for convenience we called
"trend."
Hierarchical models, usually taking the form of so-called
random-effects models, would have been an alternative.
However, these models are not conceived to identify out-
liers. Further, the theory dealing with outliers still has to
be developed for linear mixed models and it is impossible
to identify outliers in non-linear mixed models [30,31].
Finally, in the random-effects models the hospitals in the
set of data are considered a random sample from the
larger population of all hospitals, contrary to the facts in
our study.
Logistic regression [32] was performed to compare each
individual hospital with all Belgian hospitals and to deter-
mine both a practically relevant and statistical significant
departure from the national rate/trend. By incorporating
an interaction term in the logistic regression between aPage 4 of 16
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hospitals, those hospitals with an abnormal evolution in
time were identified. Precisely, we compared the slope of
each hospital's time trend with that of the national trend
using linear contrasts.
In case of common outcomes (> 10%), or if the odds ratio
is greater than 2.5 or less than 0.5, the estimation of the
relative risk by the odds ratios, provided by the logistic
regression, may become heavily biased. To reduce this
bias we used the approximation of the RR by Zhang[33],
which has been used to compute the afore-mentioned
departure. The relation between RRZ and the odds ratio is
given by RRZ = OR/((1-P0)+(P0 *OR), where P0 indicates
the incidence of the outcome of interest in the non-
exposed group [33].
In the main analysis, adjustment was made for age of the
mother and per-semester evolution of the CSRs. In a sec-
ondary analysis, type of hospital (private versus public,
teaching versus non-teaching), gestational age, admission
day and residence of the mother were considered determi-
nants, susceptible both to influence a hospitals' CSR and
to be modified by quality-directed initiatives.
To account for correlation within the data, rescaling tech-
niques were used [34]. To study a possible national
upward trend we used so-called Generalized Estimating
Equations (GEE), a refinement of logistic regression that
corrects for correlation within the data [31].
The neonatal endpoints were analyzed by multivariable
logistic regression as well. As the Apgar categories consti-
tute a multinomial endpoint, we intended to fit a propor-
tional odds logistic model, provided the assumption of a
constant odds ratio was met [35]. Otherwise, a general-
ized logit analysis was to be conducted [35].
Independence of two variables forming a contingency
table and proportions were analyzed by means of chi-
square tests. Cochran-Armitage trend tests were used
where appropriate.
These statistical analyses were performed using SAS ver-
sion 8.1, SAS Institute Inc., SAS Campus Drive, Cary,
North Carolina 27513, US.
The study being (1) of a retrospective, non-interventional
type and (2) anonymous with respect to both hospitals
and patients, no approval by an ethics committee is
required in Belgium.
Results
Completeness and accuracy of the data
According to residence of the mother, the MCD data
showed very similar to those of the NIS, indicating their
high degree of completeness regarding the number of live
births (Table 1, section 1). As to the neonatal characteris-
tics we observed an acceptable agreement between MCD
and SPE regarding multiple gestation, gestational age,
cesarean delivery, presentation, weight at birth, gender
and Apgar scores (Table 1, section 2). However, regarding
hypertension, diabetes, labor induction, epidural anesthe-
sia, and history of a previous cesarean delivery, we found
important disagreements. For the years 2001 and 2003
(see Additional file 3) almost identical figures were
observed. The comparison of the MCD data with those of
the ONE (data not shown) showed a good agreement
with respect to birth weight and Apgar scores as well.
Low risk pregnancies
Comparing the study population (381,988 deliveries
from which 12.98% CS) with the comparison population
(73,944 deliveries of live born singletons (in vertex posi-
tion) from which 49.68% CS), we found in the latter pop-
ulation a relative risk of being delivered by CS of 3.83,
95% CI (3.79; 3.87). Applying to our source population
the basic triad of "mothers with singleton, full-term (37
weeks and more) births involving a vertex presentation",
recently used to describe maternal risk profiles[21], we
would have had 395,021 low risk deliveries, giving rise to
52,611 CS and to a relative risk of 1.12, 95% CI (1.10;
1.13).
Characteristics of the study population and mode of 
delivery. Belgium 2001–2004
In the univariate analyses (see Additional file 4) several
determinants of the CS rate were identified with relevance
for the final analysis (Table 2). Increasing maternal age
was associated with increasing CSRs (Cochran-Armitage:
p < 0.01). We further found that the CSRs were not homo-
geneously distributed across birth weight and gestational
age groups (Chi-square: p < 0.01), and in particular that a
GA of >36 and <39 weeks was associated with the highest
gestational age-specific cesarean risk as was the birth
weight category of 4000–4499 g. The CSR tended to be
significantly higher for boys as compared to girls (OR:
1.14; 95% CI [1.12; 1.16]) as well. We also established an
increasing CSR trend and an inverse correlation between
the CS rate and the 1' and 5' Apgar scores (Cochran-Armit-
age trend: p < 0.01). The respiratory syndromes were all
significantly associated with the CSR: RDS, wet lung, and
MAS had odds ratios of respectively: 3.07, 95% CI (2.76;
3.44); 3.24, 95% CI (2.93; 3.59) and 1.60, 95% CI (1.45;
1.77). Similarly, neonatal interventions such as respira-
tory support and admission to a specialized neonatal serv-
ice were significantly associated with cesarean ratesPage 5 of 16
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1.30)). Finally, congenital anomalies proved another
determinant of the CSR (OR 1.35, 95% CI (1.45; 1.77).
With regard to health services characteristics, interestingly
we documented a considerably strong and statistically sig-
nificant (Chi-square: p < 0.0001) association between day
Table 1: Completeness and accuracy of the data (in %): comparison between MCD versus NIS, and between MCD versus SPE
1) Comparison between MCD* and NIS°: number and distribution of live born infants, according to residence
2002 2004
Residence MCD NIS MCD NIS
Belgium (N = 111,609) (N = 111,225) (N = 116,142) (N = 115,618)
Flanders 53.1 53.7 53.0 53.9
Wallonia 33.2 33.8 32.4 32.9
Brussels 13.1 12.5 13.8 13.1
Abroad 0.6 - 0.8 -
2) Comparison between MCD and SPE+: perinatal characteristics
2002 2004
Deliveries MCD NIS MCD NIS
(N = 58,194) (N = 58,841) (N = 59,126) (N = 61,647)
Multiple gestation
twins 2.3 2.0 2.0 1.6
triplets 0.1 0.0 0.1 0.0
Hypertension 5.5 4.9 5.8 4.8
Diabetes 1.6 1.2 2.1 1.4
Gestational age
20–31 weeks 1.0 1.0 1.1 1.1
32–36 weeks 6.1 6.3 6.4 6.5
>= 37 weeks 92.9 92.7 92.8 92.5
Labor induction 19.4 30.1 17.7 27.6
Epidural anesthesia 48.3 63.2 51.3 61.6
Cesarean delivery 18.1 17.7 18.5 18.3
Previous cesarean 4.6 7.6 5.7 8.2
Births MCD NIS MCD NIS
(N = 58,529) (N = 60,048) (N = 59,110) (N = 62,657)
Presentation
breech 4.5 5.4 4.5 5.2
transverse 0.5 0.6 0.4 0.5
Type of birth
spontaneous 72.5 69.9 71.3 70.2
vacuum 8.5 10.3 9.1 9.7
forceps 0.6 1.1 0.5 0.9
cesarean 17.9 18.3 18.2 18.9
vaginal breech 0.5 0.4 0.4 0.3
Weight at birth
<1500 g 0.8 1.2 0.8 1.1
1500–2499 g 5.6 6.2 5.4 5.8
>= 2500 g 93.3 92.7 93.7 93.1
Gender
male 51.4 51.4 51.4 51.4
female 48.6 48.6 48.6 48.6
Congenital anomalies 3.0 1.8 3.1 1.6
Admission into specialized unit 17.9 17.9 17.9 17.8
Sources
*MCD: Minimal Clinical Data
°NIS: National Institute of Statistics
+SPE: Studiecentrum Perinatale EpidemiologiePage 6 of 16
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cesarean deliveries, varying respectively between 64,422
and 14.84% on Monday; and, 33,836 and 7.21% on Sat-
urday.
Inter-hospital differences in CSR
We observed considerable and statistically significant
inter-hospital differences in CSRs both in the overall anal-
ysis and in the longitudinal analysis (Figures 1 and 2).
Regarding the period analysis, departures ranged from -65
up to +75, corresponding to nine "high CSR" and thirteen
"low CSR" outlying hospitals with CSRs of respectively
19.3% and 8.8% vs 12.9% in the "average CSR" group.
Regarding the trend, hospital-specific departures from the
national CSR trend ranged from -6 to +6 and, a difference
that did not achieve statistical significance when account-
ing for multiple comparisons. For instance, the departure,
of hospital ID 36 amounted to + 6 (Bonferroni-corrected
95% CI: -2 to +14), corresponding to a p-value of 0.01245
which does not reach the Bonferroni-corrected signifi-
cance level of 0.05/107 = 0.00047.
Apart from the figures, the feedback to the hospitals
included a table, mentioning the departures of period and
trend, as well as their Bonferroni-corrected and 95% CI,
the corresponding p-values, and an aid to the interpreta-
tion. Regarding the first ten hospitals we provide an exam-
ple of this feedback in Table 3.
National CSR and its determinants
To assess the evolution of the CSR, we fitted a multivaria-
ble GEE model, accounting for maternal age, wherein evo-
lution over time of the CSR was fitted as a linear trend.
Starting from the first semester of 2001 we found a
national increasing trend of CS of about 2% by semester
(Table 4, section a). To assess the determinants as availa-
ble in our data set, a second multivariable GEE was fitted,
thereby accounting for time and maternal age as covari-
ates, and determinants listed in table 4. Compared to
cesarean risk associated with hospital admission on Sun-
day, we observed increased CSRs in case of an admission
from Monday to Thursday, while the cesarean risk again
decreased with admissions on Friday and Saturday. Deliv-
Table 2: Study population: characteristics and mode of delivery. Belgium 2001–2004.
CS % Total CS % Total
1) Maternal 2) Neonatal
Age classes Gender
< 20 years 765 9.40 8,140 Boys 26,862 13.69 196,191
20–24 years 5,910 10.37 57,010 Girls 22,713 12.23 185,755
25–29 years 15,987 11.92 134,071 Undetermined 3 23
30–34 years 17,342 13.75 126,098 Birth weight
35–39 years 7,746 16.27 47,613 2500–2999 g 9,444 13.78 68,511
40 years+ 1,828 20.18 9,057 3000–3499 g 20,431 12.18 167,699
Admission Day 3500–3999 g 15,119 12.89 117,250
Monday 9,560 14.84 64,422 4000–4499 g 4,584 16.07 28,529
Tuesday 8,827 13.80 63,948 Gestational age group
Wednesday 8,780 14.22 61,762 37–38 weeks 18,531 18.77 98,712
Thursday 8,961 14.29 62,729 39–40 weeks 25,628 10.56 242,645
Friday 5,212 10.73 48,555 41–42 weeks 5,419 13.34 40,632
Saturday 2,441 7.21 33,836 1 min Apgar
Sunday 5,797 12.40 46,737 Missing 10 16.13 62
Semester < 4 1,141 21.61 5,281
2001-1 5,672 11.99 47,287 4 – 6 2,857 14.65 19,507
2001-2 5,975 12.43 48,058 > 6 45,570 12.76 357,139
2002-1 5,757 12.51 46,023 5 min Apgar
2002-2 6,254 13.14 47,605 Missing 10 15.38 65
2003-1 6,161 13.27 46,421 < 4 163 21.73 750
2003-2 6,550 13.55 48,356 4 – 6 703 18.03 3,898
2004-1 6,319 13.24 47,734 > 6 48,702 12.91 377,276
2004-2 6,890 13.64 50,505 Respiratory Syndromes
RDS 480 31.27 1,535
Wet lung 552 32.43 1,702
Meconium Aspiration 510 19.23 2,652
Intubation/Ventilation 959 27.88 3,440
Congenital Anomaly 559 16.57 3,374
Admission N*/NICU 9,850 15.31 64,326
CS: number of cesarean sections carried out; %: proportion of the cesarean deliveries expressed as a percentage; Total: total number of deliveries 
with the characteristic under study.Page 7 of 16
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with a significantly increased CSR as compared to 39–40
weeks as well, whereas we were not able to detect a signif-
icant association between type of ownership or teaching
status of the hospitals and mode of delivery.
Neonatal outcomes
The bivariate distribution of the neonatal endpoints,
according to mode of delivery and CSR group is given in
Table 5. With the exception of RDS after a vaginal delivery,
all the endpoints were unevenly distributed (p < 0.01)
across CSR groups. 1- and 5-minute "Apgar 0–3" scores
were more frequent in case of CS and in the "low CSR"
group. However, note that the proportion of these scores
in the "low CSR" group versus "high CSR" group is
smaller in case of a vaginal delivery than after a CS.
Regarding RDS and MAS, we observed in the three CSR
groups almost identical incidences after a vaginal delivery.
The incidences after CS, however, were significantly dis-
similar. Indeed, the "average CSR" group seemed to have
a smaller RDS incidence, whereas a smaller MAS inci-
dence seemed to prevail in the "high CSR" group. TTN
seemed to be less problematic in the "high CSR" group,
regardless of the mode of delivery. In the "low CSR"
group, the need for respiratory assistance seemed more
important in both modes of delivery.
The discrepancies regarding the distribution of newborns
admitted into a specialized service were striking: the inci-
dences of transfer in the "high CSR" group were five times
smaller, regardless of mode of delivery. However, one
should be very cautious regarding the variable "admitted
into a specialized neonatal service". Indeed, according to
this variable, in the "high CSR" group 342 out of 395 new-
borns with a 1-minute Apgar of 0 to 3 and 1713 out of
1861 newborns with a 1 minute Apgar of 4 to 6 would not
have been admitted into a specialized service, which seem
hardly plausible figures.
Since the proportional odds assumption was not met, a
general logit analysis was carried out to analyze the asso-
ciation between mode of delivery, CSR group and 1-
minute Apgar and 5-minute Apgar scores in a more formal
way. In the 1-minute Apgar analysis, it appeared that there
were significantly fewer cases of "Apgar 0–3" scores in the
"high" CSR group than in the "average" CSR group, which
in turn was significantly less associated with "Apgar 0–3"
scores than the "low CSR" group (Table 6). Regarding the
"Apgar 4–6" scores we no longer found a significant dif-
ference between "average" CSR group and "high" CSR
group, whereas the difference between "average CSR" and
"low CSR" groups remained significant. Note that cesar-
ean delivery and male gender were negatively associated
with the Apgar scores. The 5-minute Apgar analysis essen-
tially gave the same results.
We also investigated the association between mode of
delivery, CSR group and respiratory syndromes, certain
types of respiration sustaining treatments or the admis-
sion of the newborn into a specialized neonatal pediatric
service/NICU (see Additional file 5). For all the endpoints
considered, CS was significantly associated with an
increased occurrence of negative outcomes. For male gen-
der, with the exception of MAS, we observed a similar rela-
tionship.
Comparing the "high CSR" and "low CSR" with the "aver-
age CSR" group, the "low CSR" group showed an impor-
tant excess of RDS cases in case of cesarean delivery.
Regarding MAS, and comparing the "low CSR" and "aver-
age CSR" groups, we found an excess of MAS cases in the
"average CSR" group regardless of mode of delivery. In
part, this phenomenon may be due to the adjustment by
gestational age, since a significant excess of deliveries at 41
and 42 weeks was observed in the "low CSR" group (RR:
Inter-hospital differences in CSR, trendFigure 2
Inter-hospital differences in CSR, trend. Belgium, 2001–4.
Inter-hospital differences in CSR, periodFigure 1
Inter-hospital differences in CSR, period. Belgium, 2001–4.Page 8 of 16
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observed an important excess of cases in the "low CSR"
group.
Respiratory support seemed more often needed in the
"low CSR" group (OR: 1.27; 95% CI [1.14; 1.43]). Neona-
tal admission into a specialized service seemed inversely
associated with the "high CSR" (OR: 0.11; 95% CI [0.10;0.
12]) and "low CSR" (OR: 0.86; 95% CI [0.84;0. 89])
groups, especially in case of a vaginal delivery. But as
afore-mentioned one should be very cautious when inter-
preting this endpoint.
Deliveries at 37–38 weeks and at 41–42 weeks were asso-
ciated with an excess of all the considered endpoints.
Comparing the CSR groups regarding the ratio of CS car-
ried out at that gestational age over the total number of
CS, we found 40.1% in the "high CSR" group versus
24.2% and 37.2% respectively in the "low CSR" and
"average CSR" groups.
The relationship between gestational age and MAS was a
peculiar one in the sense that it was significantly negative
at a gestational age of 37–38 weeks and significantly pos-
itive at a gestational age of 41–42 weeks.
The results of our analyses excluding cases of congenital
anomaly were essentially the same (see Additional file 6).
Discussion
Main findings
Our results suggested the existence of sizeable and nation-
wide inter-hospital variations in CSRs in low-risk deliver-
ies. They rested on a very conservative analysis and inter-
pretational approach, consisting both in defining a zone
of non-interpretation and in the use of considerable
threshold values before a departure from the national rate
or trend was labeled important and statistically signifi-
cant. We adjusted for multiple simultaneous comparisons
and for presence of correlation within the data[31,34],
and provided degrees of evidence regarding the observed
departure of a hospital, as well as an interpretational aid.,
thereby avoiding false alerts and reassurance, and allow-
ing distinction between real differences and artefacts [36].
We observed an evolution over time of the CSR, which
was best summarized by a national upward trend of 2%
by semester. We observed that obstetrical intervention
drastically pervaded childbirth as is reflected by the geo-
graphical and hospital-related distributions of CSR, and
the distribution of number and mode of deliveries by
admission day [37]. Structural issues (nurse staffing, avail-
ability of physicians and anesthesiology), not registered in
the MCD, may also have intervened in the decision
towards elective cesarean section [38].
Table 3: Departure of a hospital's CSR (expressed as a percentage) from the national CSR or trend, Belgium, 2001–4.
ID1 Period Trend IP10
LB_B2 LB_953 D(%)4 UB_955 UB_B6 CI_957 CI_B8 P9 LB_B2 LB_953 D(%)4 UB_955 UB_B6 CI_957 CI_B8 P9
1 -18 -10 3 16 28 NS NS 0.68283 -11 -7 -2 4 8 NS NS 0.51065 GM
2 24 33 44 56 66 + + <0.00001 -8 -5 -1 3 6 NS NS 0.57928 EA
3 -20 -10 5 23 38 NS NS 0.49978 -16 -11 -5 2 8 NS NS 0.18024 GM
4 9 18 31 44 56 + + <0.00001 -8 -4 0 5 9 NS NS 0.90712 GM
5 -20 -11 1 15 27 NS NS 0.88383 -10 -6 0 5 10 NS NS 0.93539 GM
6 9 14 21 29 35 + + <0.00001 0 2 5 8 10 + NS 0.00045 GM
7 0 7 16 26 35 + NS 0.00061 -9 -7 -3 1 4 NS NS 0.11081 GM
8 -32 -26 -19 -11 -5 - - <0.00001 -10 -7 -3 1 4 NS NS 0.10727 GM
9 -12 -7 1 10 17 NS NS 0.75745 -2 1 4 8 11 + NS 0.01709 GM
10 -45 -40 -33 -26 -19 - - <0.00001 -7 -3 1 6 9 NS NS 0.67442 EA
1 ID: Anonymous hospital identifier;
2 LB_B: Lower bound of the Bonferroni confidence interval;
3 LB_95: Lower bound of the 95% confidence interval;
4 D: departure of a hospital's CSR compared with the national CSR/national trend;
5 UB_95: Upper bound of the 95% confidence interval;
6 UB_B: Upper bound of the Bonferroni confidence interval;
7 CI_95: +: a 95% CI suggests a significantly higher hospital's rate/trend compared with the national rate/trend,
-: a 95% CI suggests a significantly lower hospital's rate/trend compared with the national rate/trend,
NS: a 95% CI does not suggest a significant departure of the hospital's rate/trend compared with the national rate/trend.
8 CI_B: +: a Bonferroni-corrected CI strongly suggests a significantly higher hospital's rate/trend compared with the national rate/trend,
-: a Bonferroni-corrected CI strongly suggests a significantly lower hospital's rate/trend compared with the national rate/trend,
NS: a Bonferroni-corrected CI does not suggest a significant departure of the hospital's rate/trend compared with the national rate/trend.
9 P value: Probability of observing departures such as these assuming the null hypothesis of no departure is true.
10IP: Interpretation: EA: External audit and general measures recommended; GM: General measures recommended.Page 9 of 16
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Limitations in completeness and accuracy are intrinsic to
vital-statistics and administrative data [22,39] Our labor-
induction, epidural anesthesia and history of a previous
cesarean data are incomplete, and we observed a possible
over-registration of hypertension and diabetes as well
(Table 1). The miscoding of these conditions may induce
serious flaws in the inter-hospital comparison. Indeed,
each of them is related with higher CSRs and may reflect
differences in medical or coding practices across hospitals.
Therefore, given the magnitude both of the occurrence of
these conditions and of the miscoding, we omitted them
in the definition of our study population, whereas we
used the term screening for inter-hospital differences,
which should be completed by external or internal audits.
Owing to the very nature of our data, we were unable to
formally distinguish between primary elective and repeat
cesareans. This can be viewed as another limitation, and,
while further analyses of the primary elective cesareans are
of major interest as they are the first starting point to con-
tain rising CSRs, the joint analysis is of use for the research
question central in this work. Consequently, to avoid
flawed inter-hospital comparisons and to improve the
effectiveness of the CSR as a quality indicator, multi-fac-
Table 4: CSR evolution and determinants. Belgium 2001–4.
OR P
a) National trend adjusted for age group
Semestrial trend (basis 1st semester 2001) 1.02 (1.02; 1.02) <0.01
Age group
20–24 years vs < 20 years 1.11 (1.11; 1.11) <0.01
25–29 years vs < 20 years 1.30 (1.30; 1.30) <0.01
30–34 years vs < 20 years 1.53 (1.53; 1.53) <0.01
35–39 years vs < 20 years 1.86 (1.86; 1.86) <0.01
40 years+ vs < 20 years 2.41 (2.41; 2.41) <0.01
b) National trend of CSR and determinants
Semestrial trend (basis 1st semester 2001) 1.02 (1.01; 1.02) <0.01
Age group
20–24 years vs < 20 years 1.12 (1.09; 1.22) 0.02
25–29 years vs < 20 years 1.31 (1.20; 1.43) <0.01
30–34 years vs < 20 years 1.55 (1.42; 1.69) <0.01
35–39 years vs < 20 years 1.89 (1.73; 2.07) <0.01
40 years+ vs < 20 years 2.45 (2.21; 2.71) <0.01
Gestational age
37–38 weeks vs 39–40 weeks 1.93 (1.87; 2.00) <0.01
41–42 weeks vs 39–40 weeks 1.31 (1.26; 1.36) <0.01
Residence
Antwerp vs National 1.00 (0.94; 1.05) 0.73
Brussels vs National 0.89 (0.84; 0.94) <0.01
Brabant (F) vs National 0.97 (0.91; 1.05) 0.29
Brabant (W) vs National 0.82 (0.75; 0.89) <0.01
West Flanders vs National 1.10 (1.02; 1.18) 0.01
East Flanders vs National 1.06 (1.00; 1.13) <0.01
Hainaut vs National 0.94 (0.88; 1.00) <0.01
Liège vs National 1.34 (1.25; 1.44) <0.01
Limburg vs National 1.24 (1.14; 1.34) <0.01
Luxembourg vs National 1.01 (0.86; 1.18) 0.92
Namur vs National 0.83 (0.77; 0.90) <0.01
Abroad vs National 0.93 (0.79; 1.09) 0.20
Admission day
Monday vs Sunday 1.22 (1.15; 1.29) <0.01
Tuesday vs Sunday 1.13 (1.06; 1.19) <0.01
Wednesday vs Sunday 1.17 (1.10; 1.23) <0.01
Thursday vs Sunday 1.17 (1.11; 1.24) <0.01
Friday vs Sunday 0.85 (0.80; 0.90) <0.01
Saturday vs Sunday 0.55 (0.52; 0.59) <0.01
OR: odds ratio; () 95% confidence interval;Page 10 of 16
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the hospitals, the adoption of explicitly to-filled-out
items, quality control of the data and audits are required.
Also our definition of a low-risk group, building on the
definition from the AHRQ[1], which includes the basic
triad of "mothers with singleton, full-term (>37 weeks)
births involving a vertex presentation[21]," may have
been incomplete. Kabir et al. for instance used more elab-
orated selection criteria, based on ICD-9CM codes[40],
including diabetes, hypertensive disorders, placenta pre-
via and certain congenital anomalies. Although the medi-
cal necessity of systematically carrying out a CS in case of
diabetes without macrosomia [41] and hypertensive dis-
Table 5: Neonatal endpoints according to mode of delivery and CSR group. Belgium 2001–4.
CSR groups
High (%) Average (%) Low (%) Total P
1 min Apgar Vaginal
< 4 299 1.05 3,169 1.22 672 1.52 4,140 <0.01
4 – 6 1,512 5.31 12,857 4.95 2,281 5.16 16,650
>6 26,680 93.64 243,671 93.83 41,218 93.31 311,569
CS
< 4 96 1.41 918 2.38 127 2.98 1,141 <0.01
4 – 6 349 5.14 2,223 5.77 285 6.68 2,857
>6 6,351 93.45 35,366 91.84 3,853 90.34 45,570
5 min Apgar Vaginal
< 4 32 0.11 478 0.18 77 0.17 587 <0.01
4 – 6 180 0.63 2,533 0.98 482 1.09 3195
>6 28,279 99.26 256,686 98.84 43,609 98.73 328,574
CS
< 4 11 0.16 135 0.35 17 0.40 163 <0.01
4 – 6 51 0.75 564 1.46 88 2.06 703
>6 6,734 99.09 37,808 98.18 4,160 97.54 48,702
RDS Vaginal
Absent 28,405 99.68 258,913 99.69 44,038 99.66 331,356 0.73
Present 90 0.32 816 0.31 149 0.34 1,055
CS
Absent 6,718 98.84 38,174 99.12 4,206 98.57 49,098 <0.01
Present 79 1.16 340 0.88 61 1.43 480
MAS Vaginal
Absent 28,331 99.42 257,974 99.32 43,964 99.50 330,269 <0.01
Present 164 0.58 1,755 0.68 223 0.50 2,142
CS
Absent 6,744 99.22 38,116 98.97 4,208 98.62 49,068 <0.01
Present 53 0.78 398 1.03 59 1.38 510
TTN Vaginal
Absent 28,425 99.75 258,814 99.65 44,022 99.63 331,261 <0.01
Present 70 0.25 915 0.35 165 0.37 1,150
CS
Absent 6,740 99.16 38,082 98.88 4,204 98.52 49,026 <0.01
Present 57 0.84 432 1.12 63 1.48 552
Intubation/Ventilation Vaginal
Absent 28,295 99.30 257,854 99.28 43,781 99.08 329,930 <0.01
Present 200 0.70 1,875 0.72 406 0.92 2,481
CS
Absent 6,670 98.13 37,804 98.16 4,145 97.14 48,619 <0.01
Present 127 1.87 710 1.84 122 2.86 959
Admission to specialized neonatal service Vaginal
Absent 27,818 97.62 212,951 81.99 37,166 84.11 277,935 <0.01
Present 677 2.38 46,778 18.01 7,021 15.89 54,476
CS
Absent 6,459 95.03 29,950 77.76 3,319 77.78 39,728 <0.01
Present 338 4.97 8,564 22.24 948 22.22 9,850
(%): Column percentagePage 11 of 16
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distress persisting beyond 10–15 minutes) [42] has not
yet univocally been established, current practices are asso-
ciated with higher caesarean rates. Conversely, mothers
suffering from pathologies such as placenta previa and
congenital anomalies may be considered at risk of rightly
undergoing a CS.
Due to weak case identification from administrative data
[17,36], we adopted an intermediate position to define
our study population. Yet, it may be acknowledged that
applying our criteria to our source population instead of
the basic triads criteria would have resulted in a further
12% risk reduction.
A further shortcoming of our study is the absence of
maternal endpoints. Although severe under-registration
has been observed in several countries in Europe [43], the
maternal mortality rate may be useful in inter-country
comparisons, but the low incidence of maternal deaths, 8
cases in our study population out of 12 cases in the pop-
ulation of live born infants, prevent inter-hospital com-
parisons [43]. Maternal morbidity, the other maternal
endpoint has not yet been defined clearly, though proba-
bly a very useful indicator of obstetric care [43]. Condi-
tions with permanent disability of the mother such as
infertility, vaginal fistulae are exceptional in Europe [43].
"Near misses" or "life-threatening events" and risks of
pregnancy and childbirth-related injuries leading to uri-
nary and fecal incontinence are considered as possible
indicators for maternal morbidity, which are to be made
operational in useful indicators [43]. However, these indi-
cators, when based on administrative data, are akin to
patient safety indicators type and may share its limita-
Table 6: Association of CSR group, mode of delivery and 1-minute or 5-minute Apgar scores, adjusted for gender, age class and 
semester. Belgium, 2001–4.
Response Variable OR P
a) 1 minute Apgar
Male vs Female Apgar 0–3 1.32 (1.25; 1.40) <0.01
Apgar 4–6 1.22 (1.19; 1.26) <0.01
CS vs VD Apgar 0–3 1.76 (1.59; 1.95) <0.01
Apgar 4–6 1.17 (1.10; 1.24) <0.01
CSR group: High vs Low Apgar 0–3 0.56 (0.48; 0.65) <0.01
Apgar 4–6 0.87 (0.80; 0.95) <0.01
CSR group: High vs Average Apgar 0–3 0.71 (0.48; 0.80) <0.01
Apgar 4–6 0.97 (0.91; 1.03) 0.33
CSR group: Low vs Average Apgar 0–3 1.27 (1.14; 1.40) <0.01
Apgar 4–6 1.12 (1.04; 1.19) <0.01
Average and CS vs High and VD Apgar 0–3 1.22 (1.08; 1.37) 0.02
Apgar 4–6 1.11 (1.04; 1.18) <0.01
Average and CS vs Low and VD Apgar 0–3 0.99 (0.90; 1.10) 0.88
Apgar 4–6 0.94 (0.88; 1.01) 0.08
High and CS vs Low and VD Apgar 0–3 0.82 (0.70; 0.95) 0.02
Apgar 4–6 0.85 (0.78; 0.93) <0.01
b) 5 minute Apgar
Male vs Female Apgar 0–3 1.29 (1.12; 1.49) <0.01
Apgar 4–6 1.31 (1.23; 1.40) <0.01
CS vs VD Apgar 0–3 1.84 (1.37; 2.47) <0.01
Apgar 4–6 1.52 (1.33; 1.74) <0.01
CSR group: High vs Low Apgar 0–3 0.51 (0.33; 0.79) <0.01
Apgar 4–6 0.45 (0.37; 0.55) <0.01
CSR group: High vs Average Apgar 0–3 0.53 (0.37; 0.76) <0.01
Apgar 4–6 0.57 (0.49; 0.68) <0.01
CSR group: Low vs Average Apgar 0–3 1.04 (0.79; 1.38) 0.78
Apgar 4–6 1.27 (1.12; 1.43) <0.01
Average and CS vs High and VD Apgar 0–3 1.15 (0.80; 1.64) 0.45
Apgar 4–6 1.13 (0.96; 1.33) 0.15
Average and CS vs Low and VD Apgar 0–3 0.91 (0.69; 1.21) 0.51
Apgar 4–6 0.89 (0.78; 1.00) 0.06
High and CS vs Low and VD Apgar 0–3 0.79 (0.51; 1.22) 0.29
Apgar 4–6 0.79 (0.65; 0.96) 0.02
OR: odds ratio; () 95% CI.
CS: cesarean section. VD: vaginal delivery.Page 12 of 16
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ity improvement efforts, the validity of their use for
comparative inter-hospital purposes is still to be estab-
lished [44].
Finally, part of the limitations of administrative data may
be due to the basic tension which exists between using the
same data for reimbursement and for measuring quality.
"When the use is reimbursement, there is a tendency to
perform coding quickly and to maximize the coding of
complications and co-morbidities. When the use is to
assess quality, however, it is important for coders to have
a complete record and to restrict diagnosis coding to con-
ditions that affect patient care [45]." For instance, hyper-
tension and diabetes may intervene in the algorithm used
to determine the case mix of an admission and thus be
rewarding in financial terms, whereas this may not be the
case for labor induction, epidural anesthesia and history
of a previous cesarean.
Main strengths
The comparison of the data regarding selected variables in
our study population and the data from other sources,
presented in Table 1, showed a good match in terms of
completeness and accuracy. Research has shown that a CS
is almost always correctly classified [39]. An analysis
based on a limited number of variables with known relia-
bility may achieve an inter-hospital comparison, reasona-
bly similar to a comparison based on medical record data
[46].
Neonatal endpoints
We did not include neonatal mortality as an endpoint
because it is dependent on neonatal care, which is outside
the scope of this study, and further because neonatal mor-
tality is both a rare phenomenon and, due to the mode of
registration in Belgium, cannot be linked to the type of
delivery in case of transfer to another hospital.
Information on Apgar scores, in contrast, is rarely missing:
0.39% in an important Swedish study [47] and even less
in ours. For the time being, we lack undisputed and coun-
trywide accessible alternatives [47,48]. In addition, it is
doubtful whether a similar degree of completeness is
present regarding the other neonatal endpoints. Since we
excluded multiple births, cases of prematurity, IUGR and
malpresentation (including breech) [29,47,49] from our
study, part of the risk factors for respiratory distress have
been avoided. Unfortunately we were not able to take into
account other sources of less good Apgar scores [50].
The association of high CSRs with less 1-minute "Apgar 0–
3" scores seems in accordance with CS performed for fetal
distress and to plead in favor of this group. However, SES-
related confounding may have played a role in this rela-
tionship [50]. In this group we observed a relative excess
of these scores after a vaginal delivery, whereas one would
rather have expected an excess of such scores after a CS.
This finding may indicate a problem of over-use, espe-
cially in this group. More generally indeed, 45,104 new-
borns, not suffering from congenital anomalies and
having a 1-minute Apgar > 6, were delivered by CS. Since
evidence from Flanders, the Northern part of Belgium,
shows that about 8% of the women delivering during the
study period had a history of a previous CS[51], one may
conclude that at least an important part of them has been
delivered by a CS not carried out for strictly medical rea-
sons.
On the other hand, 574 newborns without congenital
anomalies and with 5-minute "Apgar 0–3" scores were
vaginally delivered. Similarly 3,114 of such newborns
with 5-minute "Apgar 4–6" scores were delivered vagi-
nally. Both groups might have benefited from a CS, indi-
cating a possible under-use of this procedure. Indeed, 5-
minute Apgar scores are still considered a valid predictor
of neonatal mortality [28].
As in the diagnostic area and in peer review [52], arguably
Apgar scores are subject to inter-observer variability [49].
But we may have removed some of it through the catego-
rization of the Apgar scores in agreed on classes.
The results regarding other neonatal endpoints were not
univocal and we were anxious about the completeness of
our data, given the open-ended question type of register-
ing. Our aforementioned finding in the "high CSR" group
of an important proportion of newborns with 5-minute
Apgar scores < 7 and not admitted in a specialized neona-
tal service illustrates this incompleteness. Literature data
regarding MAS, RDS and TTN showing both similarities
and important dissimilarities regarding incidence of the
pathologies and their association with Apgar scores or
mode of delivery are further arguments in favor of this
hypothesis [25,53].
Apart from these concerns, in most of these endpoints CS
seemed to be associated with less desirable neonatal out-
comes and "low CSR" hospitals seemed to perform less
well, which is consistent with the findings of another
study [38].
Some findings did not favor the "high CSR" group neither.
Indeed, deliveries at 37–38 weeks were associated with
both an excess of cesarean deliveries and of all the consid-
ered endpoints. This finding is consistent with the litera-
ture stating that elective CS should be carried out at 39–40
weeks of gestational age rather than at 37–38 weeks, often
the case in Belgium. Indeed, at the latter gestational age,
before the onset of spontaneous labor, respiratory prob-Page 13 of 16
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groups regarding the ratio of cesarean deliveries carried
out at that gestational age over the total number of CS, we
found 40.1% in the "high CSR" group versus 24.2% and
37.2% respectively in the "low CSR" and "average CSR"
groups. Of course, in the multiple analyses the fact of hav-
ing undergone a CS comes on top of the often adverse
effects from the other endpoints and determinants under
study. These considerations suggest that the "average
CSR" group might be the more adequate benchmark.
Conclusion
Despite our efforts to reduce the limitations typical of
administrative data, our results are arguably a useful
"screening," which may trigger initiatives for quality-of-
care improvement in the hospitals, rather than providing
definitive statements at this stage [54]. Indeed, the inter-
hospital differences in CSR, the national CS upward trend,
the indications of over-use and under-use, the geographi-
cally different obstetric patterns and the admission day-
related concentration of deliveries, whether or not by CS,
are such that an explanation is overdue.
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